Goutham Sunny (@medoncodoc) 's Twitter Profile
Goutham Sunny

@medoncodoc

Academic account. Oncology & #medtwitter. Passionate about Preventive & community oncology, Big data, Computational onco and AI, Health economics, Med-Ed.

ID: 99938573

calendar_today28-12-2009 12:37:39

2,2K Tweet

424 Takipçi

597 Takip Edilen

Goutham Sunny (@medoncodoc) 's Twitter Profile Photo

Beamion LUNG 1 - Zongertinib in previously treated Her2 mutated NSCLC. Phase 1 data, 71% ORR, DoR 14.1m, mPFS 12.4m. Good safety profile. Promising data. DOI: 10.1056/NEJMoa2503704 Dr Amol Akhade Dr Akhil Santhosh Narjust Florez, MD, FASCO OncoAlert

Beamion LUNG 1 - Zongertinib in previously treated Her2 mutated NSCLC. 
Phase 1 data, 71% ORR, DoR 14.1m, mPFS 12.4m. Good safety profile. Promising data. 

DOI: 10.1056/NEJMoa2503704

<a href="/SuyogCancer/">Dr Amol Akhade</a> <a href="/tuttsakhil/">Dr Akhil Santhosh</a> <a href="/NarjustFlorezMD/">Narjust Florez, MD, FASCO</a> <a href="/OncoAlert/">OncoAlert</a>